This federal contract award is a delivery order valued at $4,124.64 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for REXULTI 1 MG TABLET 30S, a specialty medication, with a period of performance through December 24, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is issued under that larger IDC framework. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen's extensive federal contracting portfolio demonstrates its critical role in supplying essential medical commodities, including specialty drugs, brand-name and generic pharmaceuticals, vaccines, and medical devices, to various government agencies and healthcare programs.
Generated 3/24/25, 9:43 AM